Rebeca Hid Cadena Wayel H Abdulahad G A P Hospers T T Wind Annemieke M H Boots Peter Heeringa Elisabeth Brouwer
10.3389/fimmu.2018.00315
Front Immunol
2018 Feb 22;9:315.
giant cell arteritis immune checkpoint inhibitors immune checkpoints immune-related adverse events vasculitis
CC BY
https://pubmed.ncbi.nlm.nih.gov/29520282/
Aging / immunology Aging / pathology Antineoplastic Agents / administration & dosage Antineoplastic Agents / adverse effects Autoimmune Diseases / chemically induced Autoimmune Diseases / immunology Autoimmune Diseases / pathology Melanoma / drug therapy Melanoma / immunology Melanoma / pathology Vasculitis / chemically induced Vasculitis / immunology Vasculitis / pathology
Aging / immunology Aging / pathology Antineoplastic Agents / administration & dosage Antineoplastic Agents / adverse effects Autoimmune Diseases / chemically induced Autoimmune Diseases / immunology Autoimmune Diseases / pathology Melanoma / drug therapy Melanoma / immunology Melanoma / pathology Vasculitis / chemically induced Vasculitis / immunology Vasculitis / pathology Case Reports Research Support, Non-U.S. Gov't Review Aged Humans Male Antineoplastic Agents
PMC5827159
29520282
Checks and Balances in Autoimmune Vasculitis
2018